COPD Awareness Month

United States, Canada, United Kingdom, Australia, New Zealand, Ireland

About

COPD Awareness Month is observed throughout November to bring greater attention to chronic obstructive pulmonary disease (COPD), a long-term condition that makes breathing difficult and can affect everyday activities. The observance helps the public better understand COPD, including its symptoms, risk factors, prevention, diagnosis, and treatment, while encouraging people to take persistent breathing concerns seriously.

Throughout the month, communities, healthcare organizations, and advocates share information and support for people living with COPD and their loved ones. It is also a meaningful time to promote lung health, encourage conversations with healthcare professionals, and recognize the strength of those managing this condition. By increasing awareness and compassion, COPD Awareness Month helps foster earlier support, informed care, and healthier lives.

History

COPD Awareness Month is observed throughout November to increase public understanding of chronic obstructive pulmonary disease (COPD), a long-term lung condition that makes breathing difficult. COPD generally includes emphysema and chronic bronchitis and is commonly associated with persistent cough, mucus production, wheezing, and breathlessness. The observance developed in response to the widespread underrecognition of the disease: many people once regarded its symptoms as an unavoidable consequence of aging or smoking rather than signs of a serious, treatable medical condition.

Its history reflects the gradual development of COPD as a distinct public-health concern. For much of the twentieth century, chronic bronchitis and emphysema were often discussed separately, even though they could produce similar patterns of lasting airflow obstruction. As medical research clarified the relationship among these conditions, international and national health organizations began promoting the broader term “COPD.” The establishment of the Global Initiative for Chronic Obstructive Lung Disease in the late 1990s helped encourage common definitions, diagnostic guidance, prevention strategies, and greater professional awareness.

Over time, COPD Awareness Month expanded beyond campaigns aimed solely at smoking cessation. Public-health organizations, hospitals, respiratory specialists, and patient advocates now use November to promote early evaluation, spirometry and other forms of testing, vaccination, pulmonary rehabilitation, medication adherence, and practical support for people living with COPD. Campaigns also emphasize that exposure to secondhand smoke, occupational dust and chemicals, indoor and outdoor air pollution, and other environmental factors can contribute to respiratory disease. This broader approach recognizes that COPD can affect people with varied histories and that earlier diagnosis may help preserve quality of life.

The observance has cultural significance because it gives patients and caregivers a shared opportunity to speak openly about a condition that is often stigmatized. By separating COPD from blame and presenting it as a complex disease influenced by genetics, environment, and personal exposures, awareness efforts encourage compassion and timely medical care. Throughout November, educational events and personal stories also draw attention to the daily realities of breathlessness, reduced mobility, and emotional strain, while reinforcing the message that prevention, treatment, and support can make a meaningful difference.

Timeline

1846
English surgeon John Hutchinson introduced the spirometer and published measurements of vital capacity, establishing a key method later used to assess airflow limitation and lung function in COPD.
1964
The U.S. Surgeon General's report Smoking and Health identified cigarette smoking as a cause of chronic bronchitis and found an association with emphysema—major conditions within COPD.
1977
Charles Fletcher and Richard Peto published their landmark study of chronic airflow obstruction, documenting the relationship between smoking and accelerated decline in lung function.
1997
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) was launched through collaboration between the National Heart, Lung, and Blood Institute and the World Health Organization to improve COPD prevention and care.
2001
GOLD issued its first Global Strategy for the Diagnosis, Management, and Prevention of COPD, providing an internationally influential framework for COPD classification and treatment.

Upcoming dates

Sources

Same day

Related